Review
Nature Reviews Cancer 8, 865-873 (November 2008) | doi:10.1038/nrc2502
Article series: Hypoxia and metabolism
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
William G. Kaelin Jr1 About the author
Abstract
The von Hippel–Lindau disease is caused by inactivating germline mutations of the VHL tumour suppressor gene and is associated with an increased risk of a variety of tumours in an allele-specific manner. The role of the heterodimeric transcription factor hypoxia-inducible factor (HIF) in the pathogenesis of VHL-defective tumours has been more firmly established during the past 5 years. In addition, there is now a greater appreciation of HIF-independent VHL functions that are relevant to tumour development, including maintenance of the primary cilium, regulation of extracellular matrix formation and turnover, and modulation of cell death in certain cell types following growth factor withdrawal or in response to other forms of stress.
- View At a Glance
Author affiliations
-
Howard Hughes Medical Institute, Chevy Chase, Maryland 20815-6789, USA, and Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Email: William_Kaelin@dfci.harvard.edu
Published online 16 October 2008
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
HIF, a missing link between metabolism and cancerNature Medicine News and Views (01 Oct 2005)
A hypoxic twist in metastasisNature Cell Biology News and Views (01 Mar 2008)
See all 4 matches for News And ViewsRESEARCH
The structure of Desulfovibrio vulgaris rubrerythrin reveals a unique combination of rubredoxin-like FeS 4 and ferritin-like diiron domainsNature Structural Biology Article (01 Jun 1996)
See all 33 matches for Research